Abstract:Introduction and Aims: Alzheimer's disease (AD) is the most common form of dementia with a complex genetic background. The cause of sporadic AD (sAD) remains largely unknown. Increasing evidence shows that genetic variations play a crucial role in sAD. P75 neurotrophin receptor (p75NTR, encoded by NGFR) plays a critical role in the pathogenesis of AD. Yet, the relationship between NGFR gene polymorphisms and AD was less studied. This study aims to analyze the relationship of NGFR gene polymorphism with the risk of AD in the Chinese Han population and amyloid-beta deposition in the ADNI cohort. Methods: This case-control association study was conducted in a Chinese Han cohort consisting of 366 sporadic AD (sAD) patients and 390 age- and sex-matched controls. Twelve tag-SNPs were selected and genotyped with a multiplex polymerase chain reaction-ligase detection reaction (PCR-LDR) method. The associations between tag-SNPs and the risk of AD were analyzed by logistic regression. Moreover, another cohort from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database was included to examine the association of one tag-SNP (rs2072446) with indicators of amyloid deposition. Kaplan-Meier survival analysis and Cox proportional hazards models were used to test the predictive abilities of rs2072446 genotypes for AD progression. The mediation effects of A beta deposition on this association were subsequently tested by mediation analyses. Results: After multiple testing corrections, one tag-SNP, rs2072446, was associated with an increased risk of sAD (additive model, OR = 1.79, P-adjustment = 0.0144). Analyses of the ADNI cohort showed that the minor allele (T) of rs2072446 was significantly associated with the heavier A beta burden, which further contributed to an increased risk of AD progression in APOE epsilon 4 non-carrier. Conclusion: Our study found that rs2072446 in NGFR is associated with both the risk of sAD in the Chinese Han population and the amyloid burden in the ADNI cohort, which reveals the role of p75NTR in AD from a genetic perspective.

Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders.

P2-436: GWAS IDENTIFIES <i>CD1A</i> AFFECTING THE RATE OF PLASMA NEUROFILAMENT LIGHT INCREASE IN NONDEMENTED ELDERS

Genome-wide Association Study of Cerebrospinal Fluid Neurofilament Light Levels in Non-Demented Elders.

Genome-wide Association Study Identifies Two Loci Influencing Plasma Neurofilament Light Levels

Neurofilament Light Chain Plasma Concentration Predicts Neurodegeneration and Clinical Progression in Nondemented Elderly Adults

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

Plasma Neurofilament Light As a Longitudinal Biomarker of Neurodegeneration in Alzheimer’s Disease

An updated analysis of the association between CD2-associated protein gene rs9349407 polymorphism and Alzheimer's disease in Chinese population

P3-435: plasma neurofilament light as a measure of neurodegeneration for nondemented individuals

Genome-wide Association Study Identifies CBFA2T3 Affecting the Rate of CSF Aβ42 Decline in Non-Demented Elders.

Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.

Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia.

Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.

A genome-wide association study of longitudinal change in CSF tau among non-demented elderly

A Genome-Wide Association Study of Α-Synuclein Levels in Cerebrospinal Fluid

Plasma Neurofilament Light Chain Levels in Alzheimer’s Disease

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain

Association of rs2072446 in the <i>NGFR</i> gene with the risk of Alzheimer's disease and amyloid- deposition in the brain

Genome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline.

Genome-wide Association Study Identifies APOE Locus Influencing Plasma P-Tau181 Levels

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease